RETA (RETA) has the following price history information. Looking back at RETA historical stock prices for the last five trading days, on September 20, 2023, RETA opened at $172.10, traded as high as $172.21 and as low as $172.10, and closed at $172.21. Trading volume was a total of 517.70K shares. On September 21, 2023, RETA opened at $172.22, traded as high as $172.36 and as low as $172.12, and closed at $172.17. Trading volume was a total of 1.94M shares. On September 22, 2023, RETA opened at $172.29, traded as high as $172.34 and as low as $172.25, and closed at $172.32. Trading volume was a total of 748.90K shares. On September 25, 2023, RETA opened at $172.34, traded as high as $172.46 and as low as $172.32, and closed at $172.36. Trading volume was a total of 1.99M shares. On September 26, 2023, RETA opened at $172.36, traded as high as $172.36 and as low as $172.36, and closed at $172.36. Trading volume was a total of 0 shares.

RETA Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into RETA shares, starting with a $10,000 purchase of RETA, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	05/27/2016
End date:	09/26/2023
Start price/share:	$14.28
End price/share:	$172.36
Dividends collected/share:	$0.00
Total return:	1,107.00%
Average Annual Total Return:	40.42%
Starting investment:	$10,000.00
Ending investment:	$120,693.62
Years:	7.34

RETA Historical Price Range
Date	Open	High	Low	Close	Volume
09/20/2023	$172.10	$172.21	$172.10	$172.21	517.70K
09/21/2023	$172.22	$172.36	$172.12	$172.17	1.94M
09/22/2023	$172.29	$172.34	$172.25	$172.32	748.90K
09/25/2023	$172.34	$172.46	$172.32	$172.36	1.99M
09/26/2023	$172.36	$172.36	$172.36	$172.36	0

About RETA

Reata Pharmaceuticals is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. Co. focuses on therapeutics for the treatment of diseases with few or no approved therapies. Co.'s main programs are in rare forms of chronic kidney disease (CKD) and a rare neurological disease. Co.'s primary product candidates include bardoxolone methyl (bardoxolone) in patients with CKD caused by Alport syndrome and omaveloxolone in patients with a neurological disorder called Friedreich's ataxia. Both bardoxolone and omaveloxolone activate the transcription factor Nrf2 to normalize mitochondrial function, restore redox balance, and resolve inflammation.

RETA Historical Closing Prices
Date	Close
09/20/2023	$172.21
09/21/2023	$172.17
09/22/2023	$172.32
09/25/2023	$172.36
09/26/2023	$172.36

Healthcare Historical Prices

RETA is categorized under the Healthcare sector; below are some other companies in the same sector: RGDO Historical Stock Prices RGDX Historical Stock Prices RGEN Historical Stock Prices RGLS Historical Stock Prices RGNX Historical Stock Prices RHE Historical Stock Prices RIGL Historical Stock Prices RIOT Historical Stock Prices RLYP Historical Stock Prices RMD Historical Stock Prices Also explore: RETA shares outstanding history Free RETA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

RETA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.